Objectives: To identify the patient-level effects of blood transfusion on postoperative outcomes and to estimate the effects of different transfusion practices on hospital-level risk-adjusted outcomes. Background: Postoperative transfusion practices and their effects on shortterm outcomes in patients undergoing noncardiac surgery are not well understood. Methods: Demographic, operative, and outcomes data for 48,720 patients undergoing general or vascular surgery at 52 hospitals between July 2012 and April 2014 were obtained. The main exposure variable was receipt of any blood transfusion within 72 hours after surgery. Thirty-day mortality, any morbidity, infectious complications, and postoperative myocardial infarction were the outcomes of interest. Propensity score matching was used to minimize confounding by indication. Hospitals were categorized as having a restrictive, average, or liberal transfusion practice based on average trigger hemoglobin values. Results: A total of 2243 (4.6%) patients received a postoperative blood transfusion. After propensity matching, a postoperative transfusion was associated with increased 30-day mortality (3.6% excess absolute risk), any morbidity (4.4% excess absolute risk), and infectious morbidity (1.0% excess absolute risk). However, a transfusion was associated with 3.5% absolute risk reduction in postoperative myocardial infarction. At the hospital level, there was a wide variation in transfusion practices. Hospitals with liberal practices were twice as likely to transfuse patients and had higher risk-adjusted mortality rates than restrictive hospitals (3.1% vs 2.2%; P = 0.002). Conclusions and Relevance: Postoperative transfusions after noncardiac surgery are associated with increased adverse postoperative outcomes, with the exception of postoperative myocardial infarction. Hospitals that are liberal in their transfusion practices have higher 30-day mortality rates, suggesting potential interventions for quality improvement.
A pproximately 2.8 million units of packed red blood cells (PRBCs) are transfused to surgical patients every year in the United States. 1 Surgical patients are at risk for bleeding and postoperative anemia, with resultant decreased oxygen delivery, tissue hypoxia, and potentially poor wound healing. Indeed, several studies show an association between low hemoglobin levels and increased morbidity and mortality after surgery. [2] [3] [4] [5] [6] PRBC transfusions are thought to offset this oxygen debt and correct the physiologic imbalance, thereby ameliorating the negative effects of postoperative anemia. 7 However, growing evidence suggests that PRBC transfusions are actually associated with worse postoperative outcomes. [8] [9] [10] [11] Several trials have demonstrated that a restrictive transfusion strategy is at least as efficacious and probably superior to a liberal transfusion strategy in critically ill patients, 12 those with septic shock, 13 and in high-risk cardiac patients undergoing hip replacement. 14 On the basis of these data, several national groups and most recently the Choosing Wisely campaign recommend against the liberal use of PRBC transfusions in most patients with hemoglobin levels above 7 g/dL (hematocrit >21%). [15] [16] [17] Despite the growing awareness of these recommendations, transfusion practices are variable. In one large observational study, Bennett-Guerrero and colleagues 18 demonstrate a wide hospital-level variation in the use of perioperative PRBC transfusions among patients undergoing cardiac surgery in the United States, independent of case-mix and hospital characteristics, a finding that had been persistently present for more than 20 years. 19 However, it is difficult to accurately define this variation, as it captures only utilization rates rather than actual transfusion practices or triggers. It is also difficult to gauge the effectiveness of PRBC transfusions in noncardiac surgical patients. A recent Cochrane review demonstrates that nearly all the efficacy evidence from clinical trials does not include patients undergoing noncardiac general surgery and there has never been a randomized clinical trial of blood transfusion in general surgical patients. 20, 21 In addition, the majority of observational studies discussing the effectiveness of transfusion in noncardiac surgical patients are limited to single-institution studies, 22, 23 lack postoperative laboratory data (eg, hemoglobin), as it is not routinely collected in clinical registries, 9 or focus specifically on intraoperative transfusions. 8, 11, 24 In this context, we assessed the hospital-level variation in PRBC transfusion practices and the patient-level effects on outcomes after noncardiac general or vascular surgery, using population-based prospectively collected data. Specifically, we (1) identify the patientlevel effects of PRBC transfusion on postoperative outcomes using causal-inference research design, (2) portray the current PRBC transfusion practices (restrictive vs liberal) at 52 hospitals in the state of Michigan, and (3) estimate the effects of the different transfusion practices on hospital-level risk-adjusted outcomes. community and academic, throughout the state. MSQC data abstraction and data quality assurance details have been described elsewhere. [25] [26] [27] In brief, specially trained data abstractors prospectively collect patient characteristics, intraoperative processes of care, postoperative laboratory results, and 30-day postoperative outcomes for patients undergoing specified general and vascular surgical operations, utilizing a sampling algorithm that minimizes selection bias. This algorithm divides each calendar year into forty-six 8-day cycles, from which the first 25 consecutive surgical operations that meet MSQC inclusion criteria are selected. The cycle rotates every 8 days to ensure that every cycle begins with a different day of the week. The MSQC does not collect data for patients younger than 18 years, those with American Society of Anesthesiologists (ASA) class 6, and those undergoing bariatric, trauma, or transplant operations, nor operations performed within 30 days of another operation captured by MSQC. Certain very high-volume operations, such as laparoscopic cholecystectomy, are limited to the first 3 cases in each cycle so that these operations do not overwhelm the database. Regular data audits ensure registry data validity in accordance with established policies and procedures. 25 Data collection for MSQC is institutional review board exempt at participating hospitals, and the current study was reviewed and deemed "nonregulated" by the University of Michigan's institutional review board.
Patient Population
Patients 18 years and older undergoing general abdominal or vascular surgery from July 2012 to April 2014 at any of 52 MSQC community and academic hospitals were included in this study.
Independent Variables
Registry-based preoperative clinical and demographic data analyzed included age, race, sex, ASA class, and body mass index. Comorbidities included preoperative cardiovascular, pulmonary, renal, hematological, gastrointestinal, and endocrine diagnoses. Operative data included the type of operation, which was derived from the respective CPT (Current Procedural Terminology) codes, surgical priority, estimated blood loss, and the use of an intraoperative transfusion.
Unique to MSQC data, postoperative laboratory results are also prospectively collected on a mandatory basis for all patients in the database when results are available. This includes the lowest recorded hemoglobin value. The lowest recorded hemoglobin value for patients who did receive a transfusion was defined as the trigger hemoglobin level. For each hospital, the aggregate mean trigger hemoglobin level and its 95% confidence interval (CI) were used to classify hospitals into those that follow a restrictive, average, or liberal transfusion practice. To provide a qualitatively conservative impression, the overall population mean of trigger hemoglobin levels was used as the threshold rather than a predefined hemoglobin value. Hospitals whose 95% CI upper bound was less than the mean were classified as following a restrictive practice, those with 95% CI that included the mean were classified to follow an average practice, and those with 95% CI lower bounds that were greater than the mean were classified to follow a liberal transfusion practice.
Main Exposure and Outcome Measures
Receipt of a blood transfusion within 72 hours after the index operation was the main exposure variable in this study. The main outcome measures were 30-day mortality and 30-day morbidity. Morbidity was defined as having documentation of at least 1 postoperative complication, including superficial surgical site infection, deep space surgical site infection, organ space surgical site infection, wound dehiscence, pneumonia, unplanned intubation, pulmonary embolism, ventilator dependence of more than 48 hours, acute kidney injury, urinary tract infection, neurologic event, cardiac arrest, myocardial infarction, venous thromboembolism (deep vein thrombosis or pulmonary embolism), sepsis, severe sepsis, central line-associated blood stream infection, Clostridium difficile infection, and anastomotic leak. Secondary outcomes included the development of any infectious complication and the occurrence of postoperative myocardial infarction within 30 days from the index operation.
Statistical Analyses
Clinical and demographic variables for patients, who did or did not receive a postoperative blood transfusion after noncardiac surgery at 1 of 52 MSQC hospitals, were analyzed using χ 2 tests for categorical variables and Student t tests for continuous variables as indicated. To minimize selection bias in this observational study, we used propensity score matching. Propensity score matching allows for comparisons between patients receiving a treatment (transfusion) and a similar group of patients not receiving it but having a similar surgical risk profile. The propensity score is the probability from 0 to 1 of each patient receiving a postoperative transfusion, given a set of known variables, and is used to reduce potential selection bias, confounding, and differences between treatment groups in observational studies. [28] [29] [30] The propensity score-matching approach was accomplished in 2 steps. First, the probability of receiving a postoperative transfusion was modeled using multiple logistic regressions with 29 patient and operative variables and 38 procedure types (Tables 1  and 2 ; and see Supplemental Digital Content eTable 1, available at http://links.lww.com/SLA/A794). From this regression, the propensity score for receiving a postoperative transfusion was computed for each patient. Second, the transfused patients were matched 1:1 to patients in the nontransfusion group based on a k-nearest neighbor match algorithm with common support restriction. The ability of matching was assessed visually (see Supplemental Digital Content eFigure 1, available at http://links.lww.com/SLA/A795), and the ability of the propensity score to balance baseline characteristics was assessed by calculating standardized % bias. The standardized % bias is the % difference of the sample means in the treated and nontreated (full or matched) subsamples as a percentage of the square root of the average of the sample variances in the transfused and nontransfused groups. Our primary metric for the propensity score analysis was the average treatment effect on the treated, which in this case is the difference between the incidence of adverse outcomes in patients who were transfused and those who were not, and can be interpreted as the excess absolute (attributable) risk. Robust Abadie-Imbens standard errors were calculated around the point estimates. 31 In a sensitivity analysis to assess the sampling variability in the propensity score model and to account for variation induced by the matching procedure, a standard bootstrapping algorithm (random with replacement) was employed to resample the cohort 1000 times and compute 95% CIs, and the results were qualitatively similar.
Hospital-level Risk Adjustment
Multivariable logistic regression models for mortality and morbidity were constructed with robust standard errors to account for patient clustering within hospitals. These models yielded patientlevel predicted probabilities and risk scores for each outcome across all hospitals. Predicted probabilities were summed at the hospital level to estimate risk-adjusted rates for each outcome of interest. For each hospital, the observed number of events (O) was divided by the risk-adjusted expected number of events (E) to produce observed-toexpected (O/E) ratios. Multiplying the O/E ratio by the mean outcome rate yields the risk-adjusted rate for that hospital. The models were evaluated for discrimination using the c-statistic. The c-statistic evaluates model discrimination and represents the area under the receiveroperator-characteristic curve. Finally, the hospital-level risk-adjusted rates were stratified by the transfusion practice classifications (restrictive, average, liberal) and compared using 1-way analysis of variance with the Scheffe method for multiple comparisons.
All statistical analyses were conducted using STATA special edition (version 13.1; StataCorp LP, College Station, TX). All tests are 2-sided, with significance set at a P value of less than 0.05.
RESULTS

Patient Level
Of the 48,720 patients undergoing noncardiac surgery at 52 hospitals between July 2012 and April 2014, a total of 2243 (4.6%) patients received a PRBC transfusion within 72 hours after the operation. As outlined in Table 1 , patients who received a transfusion were older, had higher ASA classes, and more comorbid conditions. Patients receiving a transfusion had greater volumes of estimated blood loss intraoperatively and were also more likely to have had emergency surgery ( Table 2) . Also of note is that transfusions were more common postoperatively than intraoperatively, and 15% of those transfused postoperatively also received an intraoperative transfusion.
Patients who received a transfusion had different procedures as compared with those not receiving a transfusion. For example, the most common procedures associated with a transfusion were partial colectomy or lower extremity bypass, whereas patients who did not receive a transfusion were most likely to have had undergone laparoscopic cholecystectomy or laparoscopic appendectomy (see Supplemental Digital Content eTable 1, available at http://links.lww.com/SLA/A794). Tables 1 and 2 also show the wellbalanced distribution of patient characteristics after the propensity score-matching algorithm and the respective standardized bias after matching. Standardized biases of less than 10% after matching are not significant. Of note, approximately 80% of the matched cohort had preoperative anemia.
As outlined in Table 3 , a postoperative transfusion was associated with increased 30-day mortality (3.6% excess absolute risk), morbidity (4.4% excess absolute risk), and infectious morbidity (1.0% excess absolute risk). However, a transfusion was associated with a 3.5% absolute risk reduction in postoperative myocardial infarction.
Hospital-level Results
The hospital-level variation in transfusion practices based on trigger hemoglobin levels is portrayed in Figure 1 . Across the 52 hospitals, nearly all transfusions occurred with a trigger of 7 to 9 g/dL (mean ± SD = 7.6 g/dL ± 0.4). However, it is clear that different hospitals follow different transfusion threshold practices relative to their peers. As such, 11 hospitals were consistently following a restrictive practice, 7 hospitals were consistently following a liberal practice, and the remainder was following an average practice relative to the state. There were no statistically significant differences in transfusion practices and hospital teaching status (P > 0.2); however, 64% of hospitals with restrictive practices were larger hospitals (>500 licensed beds) as opposed to 57% of hospitals with liberal practices being smaller (<300 licensed beds; P < 0.001).
The overall risk-adjusted transfusion outcome rates are shown in Figure 2 . Hospitals following a liberal transfusion practice were almost twice as likely to transfuse the average patient and had about 40% higher risk-adjusted mortality rates than restrictive hospitals (3.1% vs 2.2%; P = 0.002); although their 30-day risk-adjusted morbidity rates were similar. All multivariable models had a c-statistic of more than 0.7, which is similar to the discrimination performance of previously published postoperative outcome models. 32 It is important to contrast the patient-level results with the hospital-level effects of transfusion practices on outcomes. The attributable risks reported herein estimate the effect of a postoperative transfusion on outcomes in patients who did receive a blood transfusion compared with a matched cohort of patients who did not. On the contrary, the hospital-level results are risk-adjusted rates for a random patient from the entire cohort being treated at a hospital with a restrictive, average, or liberal transfusion practice. FIGURE 1. Hospital-level variation in trigger hemoglobin levels for transfusion at 52 hospitals. Hospitals whose 95% CI upper bound is less than the mean (horizontal line) are classified as following a restrictive practice, those with 95% CI that include the mean are classified to follow an average practice, and those with 95% CI lower bounds that are greater than the mean are classified to follow a liberal transfusion practice. FIGURE 2. Risk-adjusted transfusion and outcome rates stratified by hospital-level transfusion practice. All models adjusted for age, sex, race, body mass index, 21 comorbid conditions, procedure type, and priority. The mortality model also adjusted for the occurrence of any complication. All models had c-statistics of more than 0.7.
by trigger hemoglobin; and (3) hospitals that follow a more liberal PRBC transfusion practice are more likely to transfuse their patients and have associated higher risk-adjusted mortality.
The increased risk for 30-day morbidity and mortality in patients receiving PRBC transfusions in this study is similar to previous studies in patients undergoing cardiac 10 and noncardiac surgery, 8, 9, 11 with notable differences. Most previous studies focus specifically on intraoperative PRBC transfusions and extrapolate the results to the postoperative period. As demonstrated herein, postoperative transfusions are much more common and most often given to patients who did not receive a transfusion intraoperatively and their effect on postoperative outcomes is substantial even after accounting for the former. Generally speaking, care outside of the operating room is of lesser acuity, more likely to be discretionary, and based on physician or house officer biases. Demonstrating the attributable risks of postoperative PRBC transfusions in the postoperative setting may aid in formulating better informed decisions.
An interesting finding in the present study is the seemingly protective effect of PRBC transfusions against the occurrence of postoperative myocardial infarction. The literature on this is divergent. In the TRICC trial, significantly increased rates of myocardial infarction were observed with a higher transfusion threshold, 12 whereas the opposite was observed in the FOCUS 14 and the TRISS 13 trials, although the numerical differences were not significant in either of these 2 trials. In a different study, our group has previously shown that PRBC transfusions have some protective effect against postoperative myocardial infarction in anemic patients undergoing vascular surgery. 33 A similar protective effect was demonstrated by Carson and colleagues 34 in the pilot MINT trial that randomized anemic patients with symptomatic coronary artery disease undergoing cardiac catheterization to a liberal or restrictive strategy. The effect seen in the present study may be partly explained by the fact that the matched cohorts had a 78% prevalence of preoperative anemia. Certainly, the inconsistent results across clinical trials and observational studies further underscore the need for a definitive trial in high-risk surgical patients, with myocardial infarction as the primary outcome and at different hemoglobin triggers.
Variation in the utilization of perioperative transfusions across hospitals has been previously reported. 18, 19, 24 However, accurate data on the actual transfusion practices and strategies are lacking. From this study, it seems that the traditional "10/30 rule" (hemoglobin of 10 g/dL, hematocrit of 30%) in guiding postoperative transfusions has largely been abandoned in the state, a finding that had not been previously noted. However, there still seems to be some hesitation in adopting 7 g/dL as the "new normal," 17 and the majority of postoperative transfusions occurred for variable triggers between 7 and 9 g/dL. By referencing the population average, our analysis both allowed comparison of the hospital transfusion practices with each other and allowed for meaningful interpretations. Hospitals that followed a more liberal transfusion practice were nearly twice as likely to transfuse the average patient and had a 41% relative increase in their risk-adjusted mortality rates.
Several national organizations have advocated the restrictive use of PRBC transfusions. These recommendations are based largely on several well-conducted randomized clinical trials, which showed equivalent or superior clinical outcomes in patients receiving blood transfusion under a restrictive versus a liberal strategy. None of these trials or subsequent evidenced-based recommendations are specific, however, to guide postoperative transfusion practices in patients undergoing noncardiac surgery. This may explain the variation seen here. Nevertheless, it is clear in this study that a restrictive practice is associated with lower utilization of PRBCs and equivalent or better outcomes at the hospital level.
This study has several limitations. First and foremost, this is an observational study with inherent potential for selection bias and confounding. The MSQC database contains extensive and reliable data on baseline preoperative, intraoperative, and postoperative variables. By matching patients by propensity scores generated from more than 60 variables, we accounted for most plausible confounders. Nevertheless, we cannot rule out inaccuracies in registry data or residual confounding due to unmeasured specifics, such as PRBC storage duration data, which are not available in the MSQC database, and may influence outcomes. However, we presume this would occur at random and should not have a sizable impact on our estimates. In addition, provider-level data were not captured in this study. Although we agree that different surgical providers Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
may have different "comfort levels" at different hemoglobin levels, hospitals are the appropriate target for quality improvement as they have the leverage to affect surgeons' practices. Furthermore, previous research has shown that provider practices are more similar within hospitals than between hospitals, 35 and hospitals have been the unit of measure for similar studies. 18, 19 Certainly, hospitals that follow more restrictive transfusion practices may also offer other evidencebased practices and that may be driving the differences in mortality. Notwithstanding these limitations, the findings in the present study are relevant to common surgical practice and fill an important knowledge gap.
CONCLUSIONS
Patients who received a postoperative transfusion after noncardiac surgery had significantly increased risks for 30-day mortality, any morbidity, and infectious complications but were less at risk for postoperative myocardial infarction. At the hospital level, there is a wide variation in transfusion practices based on hemoglobin triggers. Hospitals with liberal practices are more likely to transfuse the average patient and have higher risk-adjusted mortality rates. The findings support the use of restrictive transfusion practices after noncardiac surgery and identify a potential target for quality improvement at the hospital level.
